Insulins (Bolus): Rapid- and Short-acting
INDICATIONS
FDA
FDA
- Indicated to improve glycemic control in adults and children with diabetes mellitus.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: December 4, 2018
Citation
Béliard Veillard, Régine, and Alona Crowder. "Insulins (Bolus): Rapid- and Short-acting." Johns Hopkins Diabetes Guide, The Johns Hopkins University, 2018. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547075/4.2/Insulins__Bolus_:_Rapid__and_Short_acting. 
Béliard Veillard R, Crowder A. Insulins (Bolus): Rapid- and Short-acting. Johns Hopkins Diabetes Guide. The Johns Hopkins University; 2018. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547075/4.2/Insulins__Bolus_:_Rapid__and_Short_acting. Accessed October 31, 2025.
Béliard Veillard, R., & Crowder, A. (2018). Insulins (Bolus): Rapid- and Short-acting. In Johns Hopkins Diabetes Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547075/4.2/Insulins__Bolus_:_Rapid__and_Short_acting
Béliard Veillard R, Crowder A. Insulins (Bolus): Rapid- and Short-acting [Internet]. In: Johns Hopkins Diabetes Guide. The Johns Hopkins University; 2018. [cited 2025 October 31]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547075/4.2/Insulins__Bolus_:_Rapid__and_Short_acting.
* Article titles in AMA citation format should be in sentence-case
TY  -  ELEC
T1  -  Insulins (Bolus): Rapid- and Short-acting
ID  -  547075
A1  -  Béliard Veillard,Régine,Pharm.D.
AU  -  Crowder,Alona,PharmD
Y1  -  2018/12/04/
BT  -  Johns Hopkins Diabetes Guide
UR  -  https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547075/4.2/Insulins__Bolus_:_Rapid__and_Short_acting
PB  -  The Johns Hopkins University
DB  -  Johns Hopkins Guides
DP  -  Unbound Medicine
ER  -  

 Johns Hopkins Diabetes Guide
Johns Hopkins Diabetes Guide

